Skip to main content
. 2021 May 7;12:605766. doi: 10.3389/fimmu.2021.605766

Table 2.

Univariate and multivariate analysis of risk factors for clinical outcomes.

II-IV GVHD III-IV GVHD CIR NRM LFS
Univariate Multivariate Univariate Multivariate Univariate Multivariate Univariate Multivariate Univariate Multivariate
HR 95% Cl p value HR 95% Cl p value HR 95% Cl p value HR 95% Cl p value HR 95% Cl p value HR 95% Cl p value HR 65% Cl p value HR 65% Cl p value HR 65% Cl p value HR 65% Cl p value
Age(≥14 vs. <14yrs) 0.785 0.395-1.56 0.49 0.339 0.0921-1.25 0.088 0.506 0.1081-2.37 0.39 1.23 0.418-3.62 0.708 2.09 0.89-4.91 0.084 1.8 0.921-3.51 0.079 1.652 0.84-3.25 0.15
Treatment pre-HSCT (CAR-T vs. control) 2.36 1.18-4.75 0.016 0.956 0.263-3.47 0.945 0.873 0.241-3.17 0.836 0.791 0.295-2.12 0.641 0.827 0.38-1.8 0.631
Disease status(≥CR2 vs. CR 1) 1.09 0.557-2.15 0.769 0.494 0.152-1.6 0.239 3.87 1.09-13.7 0.027 4.1 1.13-14.84 0.031 0.774 0.344-1.74 0.54 1.54 0.808-2.93 0.192
MRD(pos vs. neg) 1.09 0.536-2.23 0.81 2.29 0.75-7.02 0.142 2.81 0.961-8.24 0.056 3.02 1.02-8.96 0.046 1.45 0.638-3.32 0.38 2.21 1.16-4.24 0.017 2.105 1.09-4.06 0.027
Poor risk chromosomes (yes vs. no) 1.5 0.76-2.95 0.245 2.48 0.735-8.17 0.125 0.709 0.236-2.13 0.543 0.622 0.263-1.47 0.271 0.614 0.313-1.21 0.151
Conditioning(TBI-based vs. Bu-based) 0.888 0.365-2.16 0.795 0.254 0.0815-8.17 0.015 0.387 0.0929-1.61 0.19 0.655 0.181-2.38 0.523 0.937 0.314-2.79 0.903 0.883 0.384-2.03 0.765
Donor type (haplo vs. MUD/MSD) 0.894 0.45-1.78 0.753 3.17 0.715-14 0.113 1.33 0.413-4.31 0.629 0.917 0.402-2.09 0.84 1.25 0.646-2.42 0.516
donor-recipients gender matched(female to male vs. others) 1.16 0.464-2.89 0.761 3.37 1.07-10.6 0.0375 1.885 0.4163-8.54 0.41 1.15 0.271-4.89 0.853 0.586 0.142-2.42 0.457 0.61 0.234-1.59 0.33
course from diagnosis to transplant (≥ median vs. <median) 0.883 0.45-1.73 0.719 0.455 0.141-1.47 0.188 2.34 0.732-7.48 0.144 0.6 0.262-1.37 0.225 1.05 0.552-1.98 0.893
MNC (≥median vs. <median) 0.59 0.303-1.15 0.3 0.996 0.351-2.82 0.934 1.11 0.412-3 0.886 0.926 0.433-1.98 0.871 1.12 0.62-2.01 0.616
CD3 (≥median vs. <median) 1.17 0.596-2.29 0.655 0.713 0.228-2.23 0.561 0.421 0.13-1.36 0.137 1.13 0.506-2.53 0.766 0.824 0.432-1.57 0.559
CD34 (≥median vs. <median) 1.01 0.511-1.98 0.986 0.682 0.219-2.12 0.51 0.413 0.129-1.32 0.128 0.916 0.408-2.06 0.834 0.576 0.303-1.1 0.096 0.644 0.34-1.22 0.18
cGVHD (limited vs. extensive vs.